Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Januvia for inflammation and vascular repair in HIV+ adults
NCT01552694Phase 3Completed
- Sponsor
- Washington University School of Medicine
- Start
- Oct 2012
- Primary completion
- Oct 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of sitagliptin in cardiovascular disease (CVD) and type 2 diabetes mellitus (T2DM), sponsored by Washington University School of Medicine. Started Oct 2012; status: completed.
02
Drugs
sitagliptin
03
Conditions
cardiovascular disease (CVD)type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01552694.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01552694.